Literature DB >> 2952365

Disruption of myofibrillar energy use: dual mechanisms that may contribute to postischemic dysfunction in stunned myocardium.

R A Greenfield, J L Swain.   

Abstract

The abnormalities in regional function produced by myocardial ischemia persist after the ischemic episode resolves. Since a close functional coupling exists between myofibrillar creatine kinase and myosin ATPase, a disruption of this coupling could adversely influence myocardial function and might provide a mechanism for the myocardial dysfunction observed. The purpose of the present study was to determine if an alteration in the activity of creatine kinase associated with the myofibril occurs in the postischemic period. Anesthetized open-chest dogs (n = 6) underwent coronary occlusion for 15 minutes, followed by reperfusion for 15 minutes. In reperfused myocardium, adenine nucleotide content was decreased (72 +/- 10% of nonischemic myocardium, p less than 0.05), documenting the presence of previous ischemia. The creatine phosphate content of reperfused myocardium returned to normal, indicating resumption of myocardial energy production. The creatine kinase activity of purified myofibrils isolated from reperfused myocardium was decreased by 17 +/- 7% compared to that of nonischemic myofibrils (p less than 0.03). In addition, the free adenosine diphosphate concentration in reperfused myocardium was calculated to be 96 microM and was less than the Km of adenosine diphosphate determined for myofibrillar creatine kinase (105 microM). The results suggest two putative mechanisms for disruption of energy use in postischemic myocardium: decreased creatine kinase activity associated with the myofibril, and limitation of substrate necessary for maximal creatine kinase activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952365     DOI: 10.1161/01.res.60.2.283

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  13 in total

Review 1.  Molecular mechanisms in "stunned" myocardium.

Authors:  W Schaper
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 2.  Myofibrillar creatine kinase and cardiac contraction.

Authors:  R Ventura-Clapier; V Veksler; J A Hoerter
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

Review 3.  Alterations in fatty acid oxidation in ischemic and reperfused myocardium.

Authors:  X Q Huang; A J Liedtke
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

4.  The role of glucose metabolism in a pig heart model of short-term hibernation.

Authors:  T A Hacker; B Renstrom; S H Nellis; A J Liedtke
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

5.  Myocardial ischemia and in vitro mitochondrial metabolic efficiency.

Authors:  L Demaison; D Moreau; L Martine; I Chaudron; A Grynberg
Journal:  Mol Cell Biochem       Date:  1996-05-24       Impact factor: 3.396

6.  Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve.

Authors:  W L Gross; M I Bak; J S Ingwall; M A Arstall; T W Smith; J L Balligand; R A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

7.  The effects of pantothenic acid, cysteine and dithiothreitol in intact, reperfused pig hearts.

Authors:  B Renstrom; A J Liedtke; S H Nellis
Journal:  Mol Cell Biochem       Date:  1991-06-26       Impact factor: 3.396

8.  Effects of the superoxide radical scavenger superoxide dismutase, and of the hydroxyl radical scavenger mannitol, on reperfusion injury in isolated rabbit hearts.

Authors:  G Ambrosio; J T Flaherty
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727

9.  Enhanced glutamate uptake into synaptic vesicles fueled by vesicle-generated ATP from phosphoenolpyruvate and ADP. Proposed role of a novel enzyme.

Authors:  Kouji Takeda; Tetsufumi Ueda
Journal:  Neurochem Res       Date:  2012-08-23       Impact factor: 3.996

10.  Role of aspirin in modulating myocardial ischemic reperfusion injury.

Authors:  S D Seth; M Maulik; S C Manchanda; S K Maulik
Journal:  Agents Actions       Date:  1994-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.